Aandeel 300430 BEIJING CHIEFTAIN CONTROL ENGINEERING TECHNOLOGY CO., LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Beijing Chieftain Control Engineering Technology Co., Ltd.

Aandelen

300430

CNE100001YS5

slotkoers Shenzhen S.E.
Andere beurzen
 00:00:00 25-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
16,99 CNY +0,30% Intraday-grafiek van Beijing Chieftain Control Engineering Technology Co., Ltd. +11,12% +18,89%
21/04 Beijing Chieftain Control Engineering Technology Co, Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 CI
2023 Beijing Chieftain Control Engineering Technology Co, Ltd. Rapporteert winstresultaten voor de negen maanden eindigend op 30 september 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date 12 July 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for the Year 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong completed the acquisition of a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers.
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 July 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Approves Cash Dividend for 2021
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
Beijing Chieftain Control Engineering Technology Co., Ltd. Proposes Final Cash Dividend for the Year 2021
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong signed a Letter of Intent to acquire a 99.22% stake in Ningxia EPPEN Biotech Co.,ltd from a group of sellers for approximately CNY 5.376 billion.
Guangzhou Longzhijie Technology Co., Ltd. announced that it expects to receive CNY 90 million in funding from Beijing Chieftain Control Engineering Technology Co., Ltd.
Beijing Chieftain Control Engineering Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
Tranche Update on Beijing Chieftain Control Engineering Technology Co., Ltd.'s Equity Buyback Plan announced on February 8, 2021.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers 300430
  4. Nieuws Beijing Chieftain Control Engineering Technology Co., Ltd.
  5. Andere talen